Morgan Stanley notes that an appellate court has reversed the ITC’s finding for countervailing duties against Moroccan and Russian phosphate imports into the U.S., though the firm’s “outlook remains largely unchanged” and this does not materially alter its “base case.” However, the firm recognizes some investors saw CVDs as “both a material and a structural positive” for U.S. phosphate producers net backs, so the reversal “likely ends” the market’s “bull case,” the analyst added. Morgan Stanley has an Equal Weight rating and $40 price target on Mosaic shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on MOS:
- RBC says ruling potentially negative for phosphate makers, especially Mosaic
- Mosaic put volume heavy and directionally bearish
- U.S. Court remands ITC fertilizer decision for further proceedings
- Early notable gainers among liquid option names on September 19th
- Mosaic reports July-August Potash revenue $489M vs. $967M last year